Literature DB >> 1636271

[An increased incidence of bacterial endocarditis in chronic inflammatory bowel diseases].

G Kreuzpaintner1, D Horstkotte, B Lösse, G Strohmeyer.   

Abstract

Of 92 consecutive patients treated for proven native valve endocarditis three had ulcerative colitis and 2 Crohn's disease. All 5 patients developed severe complications; three had to undergo emergency valve replacement. With a prevalence of 64.1/10(5) cases of inflammatory bowel disease the calculated incidence (5/92) revealed a significant over-representation of inflammatory bowel disease among patients with proven endocarditis (p less than 5.08 x 10(-9)). Possible explanations may be the suppression of cellular immune defense by therapeutic interventions, high frequency of bacteremia caused by increased permeability of the damaged mucosa for bacteria and a higher incidence of diagnostic and therapeutic interventions in this patient population. Therefore, prophylaxis for bacterial endocarditis should be carefully considered before expected bacteremias in patients with highly active inflammatory bowel disease even in the absence of cardiac factors predisposing to bacterial endocarditis.

Entities:  

Mesh:

Year:  1992        PMID: 1636271

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  3 in total

1.  Infective Endocarditis Presented as a Right Atrium Mass in a Patient with Ulcerative Colitis.

Authors:  Ali Asghar Moeinipour; Hamid Hoseinikhah; Mohamad Ali Kiani; Naser Tayyebi Meibodi; Mohammad Hassan Aelami; Ali Reza Sepehri Shamloo; Shahram Amini
Journal:  Case Rep Cardiol       Date:  2015-05-24

2.  Leclercia adecarboxylata Bacteremia in a Patient with Ulcerative Colitis.

Authors:  Amir Kashani; Morteza Chitsazan; Kendrick Che; Roger C Garrison
Journal:  Case Rep Gastrointest Med       Date:  2014-10-28

3.  Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease.

Authors:  Sardar M Shah-Khan; Sardar M Shah-Khan; Fahad Alqahtani; Justin T Kupec
Journal:  Cureus       Date:  2020-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.